Dongyao Pharmaceuticals (01875.HK) reiterates strong fundamentals and outlines clear path for future sustained growth

According to the Wisdom Financial APP, Dongyao Pharmaceutical (01875.HK) issued a voluntary announcement today regarding the recent unusual fluctuations in its stock price, sending a positive signal to the market and investors. The announcement clearly stated that the company's operations are stable, its fundamentals are good, and there is no undisclosed significant adverse information. It also disclosed the progress of integration after the merger with Pharmaron and the future growth path.